Showing results (531-540 of 5,804) with videos related to
Sort By:
Pageof 581
Drug Design, Development and Therapy|August 13, 2014
Antimycobacterial, antimicrobial, and biocompatibility properties of para-aminosalicylic acid with zinc layered hydroxide and Zn/Al layered double hydroxide nanocompositesBullo Saifullah, Mohamed E El Zowalaty, Palanisamy Arulselvan, et al.Drug Design, Development and Therapy|July 17, 2014
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting stateKyungho Jang, Seonghae Yoon, Sung-Eun Kim, et al.Drug Design, Development and Therapy|July 30, 2014
Sulforaphane reverses glucocorticoid-induced apoptosis in osteoblastic cells through regulation of the Nrf2 pathwayHao Lin, Bo Wei, Guangsheng Li, et al.Drug Design, Development and Therapy|July 22, 2014
Review of nemonoxacin with special focus on clinical developmentXiaohua Qin, Haihui HuangDrug Design, Development and Therapy|July 22, 2014
Dexmedetomidine for awake intubation and an opioid-free general anesthesia in a superobese patient with suspected difficult intubationTomasz Gaszynski, Ewelina Gaszynska, Tomasz SzewczykDrug Design, Development and Therapy|November 1, 2013
Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in ratsKenjiro Koga, Mayuri Kawamura, Hiroshi Iwase, et al.Drug Design, Development and Therapy|November 1, 2013
Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantationAndreas O Doesch, Susanne Mueller, Ceylan Akyol, et al.Drug Design, Development and Therapy|August 31, 2013
Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis BDaniel C Chao, Ke-Qin HuDrug Design, Development and Therapy|August 31, 2013
Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditionsRaymond R Tjandrawinata, Effi Setiawati, Danang Agung Yunaidi, et al.Drug Design, Development and Therapy|August 23, 2013
Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseasesMinna AllarakhiaPageof 581